Unique collaboration to support the presence of Swedish innovations in Europe

Unique collaboration to support the presence of Swedish innovations in Europe

The strategic innovation programmes Swelife and Medtech4Health, as well as EIT Health Scandinavia, are now starting a joint collaboration to strengthen Swedish life science and medical technology. The aim is to shorten the time to market introduction for Swedish innovations within life science and medical technology.

Through the collaboration, companies, researchers and public employees within life science and medical technology will be given greater opportunities to apply for funding and project support, and the funding flow will be more seamless.

Joint national initiative

The collaboration is to result in a joint national initiative. The aim is to shorten the time it takes for projects that receive support within the three initiatives to reach both the domestic and international markets.

The initiative is to lead to long-term sustainable links between Swedish and foreign innovation systems. In the short term, the aim is for projects funded within the strategic innovation programmes to also be eligible for IT Health and other European programmes within innovation, education or business development.

The collaboration is expected to lead to:

  • More opportunities for Swedish innovations to reach more European markets
  • Increased coordination of calls for applications in Sweden and in Europe
  • Stronger ties between European and Swedish innovation systems
  • More opportunities and collaboration partners for European actors connected to EIT Health

Great significance

“Our new collaboration is a pilot project. In addition to EIT Health being more closely connected to the Swedish innovation system, we also hope that the model can inspire other equivalent initiatives within EIT Health in other member countries”, says Erik Forsberg, CEO of EIT Health Scandinavia.

“For Swelife, collaboration is everything and by strengthening the collaboration between our three organisations in this way, it will greatly benefit the projects we support and, in the long term, Swedish and European life science as well”, says Peter Nordström, programme director for Swelife.

“The initiatives that we finance are also located on a global market. To work for a more efficient internationalisation of Swedish Medtech companies is in line with the remit of Medtech4Health”, says Jonas Sareld, programme director for Medtech4Health.